Name: Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 Inhibitors (IC50, Ki)
Creator: AAT Bioquest
License: https://www.aatbio.com/tou.html

Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 Inhibitors (IC50, Ki)

Structure	Compound Name	Standard Type	Standard Values (in nM)
	4-Ethylphenylamino-1,2-dimethyl-6-methylaminopyrimidinium chloride	IC50	31.62 ^[1]
	Auglurant	IC50	100000.0 ^[1]
	6-[[[1-[2-(7-Methoxy-2-oxoquinoxalin-1-yl)ethyl]piperidin-4-yl]amino]methyl]-4H-pyrido[3,2-b][1,4]oxazin-3-one	IC50	100000.0 ^[1]
	2-Methoxy-N-{[1-(4-methylpiperazin-1-yl)cyclohexyl]methyl}benzamide	IC50	5011.87 ^[1]
	CID 16015637	IC50	50118.72 ^[1]
Rows per page: 1–5 of 39

References

This online resource may be cited as follows

MLA	"Quest Database™ Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 Inhibitors (IC50, Ki)." AAT Bioquest, Inc., 23 Dec. 2025, https://www.aatbio.com/data-sets/potassium-sodium-hyperpolarization-activated-cyclic-nucleotide-gated-channel-4-inhibitors-ic50-ki.
APA	AAT Bioquest, Inc. (2025, December 23). Quest Database™ Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 Inhibitors (IC50, Ki). AAT Bioquest. https://www.aatbio.com/data-sets/potassium-sodium-hyperpolarization-activated-cyclic-nucleotide-gated-channel-4-inhibitors-ic50-ki.
BibTeX	EndNote	RefMan